IGHE and food allergy: Since omalizumab is a nonspecific anti‐IgE antibody and inhibiting IgE is the basic principle of treating a type I allergic reaction, this medicine is not restricted to specific allergens and may be effective for people with multiple food allergies, commonly found in clinical practice.